ALAFI Capital Co. LLC, 10% Owner at Intra-Cellular Therapies, Inc. (ITCI), bought 516,130 shares at $15.50 ($8.0M) on 2017-10-02, disclosed to the SEC on 2017-10-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.50 | 258,065 | $4.0M | 50.0% |
| 2 | $15.50 | 258,065 | $4.0M | 50.0% |
| Total | $15.50 avg | 516,130 | $8.0M | 100% |
| Filing → |
| ITCI | BUY | 2014-12-03 | $21K | — | Filing → |
| ITCI | BUY | 2014-11-28 | $516K | — | Filing → |
| ITCI | BUY | 2014-11-21 | $15K | — | Filing → |